Effective treatments for Covid-19 could help change the course of this pandemic – from saving lives to reducing the pressure on healthcare systems. A collective global effort is needed to fund, research, develop and bring effective treatments to people, as soon as possible.
English
Standfirst
Effective treatments for Covid-19 could help change the course of this pandemic – from saving lives to reducing the pressure on healthcare systems. A collective global effort is needed to fund, research, develop and bring effective treatments to people, as soon as possible.
Research into treatments for Covid-19 is moving at an incredible speed – with thousands of studies in progress and more than 200 potential therapies being explored.
Most of the current research focuses on repurposed drugs – if shown to be effective, these could be rapidly rolled out across the world. It will take much longer to develop new safe and effective drugs that are specific to Covid-19.
Group title
Explainers
Admin title
Explainers
Group
Admin title
Explainers
Listing layout
Mid-page image card with meta data (Vertical card)
Content
Body
From repurposed drugs to new therapies – researchers are working at incredible speed to find the best ways to treat COVID-19 patients.
We launched the COVID-19 Therapeutics Accelerator together with the Bill & Melinda Gates Foundation and Mastercard.
This is a large-scale collaboration to research, develop and bring effective treatments to market quickly and accessibly. The studies funded so far include evaluating approved drugs and creating platforms for exploring new potential treatments.
The ACT Accelerator, a global collaboration of governments and international organisations, was set up to support the development, production and equitable access to all tools that will help protect people against Covid-19.
Group title
Opinion
Admin title
Opinion
Group
Admin title
Opinion
Listing layout
Mid-page image card with meta data (Vertical card)
Content
Body
Science will show us the way out of the COVID-19 pandemic. And businesses and philanthropy can play a major role by stepping up to fund coronavirus treatments, as well as vaccines and tests.
Title
Treatments will take the fear and helplessness out of coronavirus – here’s how businesses can help find them
Jeremy Farrar: "We'll look back at this time decades from now. We’ll remember the medics, carers and nurses who sacrificed so much. But we’ll also remember that science showed us the way out of this pandemic."
The COVID-19 Therapeutics Accelerator is funding clinical trials that will answer whether the anti-malarial drugs hydroxychloroquine and chloroquine can be used to prevent the spread of COVID-19.
Title
Can chloroquine prevent coronavirus disease? Only research will give us the answer
Both hydroxychloroquine and chloroquine have been approved as safe and effective drugs to treat malaria. But no large-scale clinical trials have taken place in humans to prove whether they're effective against COVID-19.
We want to help the world overcome Covid-19. Research is the best way to save lives – but more investment in accessible treatments, tests and vaccines is urgently needed to change the course of the pandemic.
Title
Coronavirus (Covid-19): supporting global research and development
A vaccine could dramatically slow the spread of coronavirus, and researchers are collaborating like never before to develop one in record time. Without a vaccine, distributed equitably all over the world, we could face recurring waves of the epidemic.
Wellcome, with photography by Pedro Vilela / Stringer / Getty Images
File size
1484895 bytes
Image width
3333px
Image height
1204px
Filename
coronavirus-covid-19-vaccine.jpg
Image
Download allowed
On
Body
At least $8 billion of new funding is needed for the global response to COVID-19 – for research, development and supply of treatments for all, and support for public health measures in countries with the weakest health systems.
Title
Urgent funding gaps in the global response to coronavirus (COVID-19)
